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Abstract
Background: IFN-γ is a multifunctional peptide with a potent immune defense function which is
also known as a prototypic Th1 cytokine. While screening for genes differentially expressed by Th1
and Th2 cytokines, human thioredoxin was identified as a novel target gene induced by IFN-γ. The
mechanism by which thioredoxin is induced by IFN-γ and the signaling pathways involved in its
induction were analyzed. In addition, the effects of thioredoxin on immune cell survival and
cytokine production were examined by thioredoxin over-expression and recombinant thioredoxin
treatment.
Results: Human thioredoxin was selectively induced by IFN-γ in monocytic and T cell lines. In
monocytic cells, the induction of thioredoxin gene expression by IFN-γ was dose-dependent, and
both the mRNA and protein levels were increased by 2~3 fold within 4 to 24 h hours of IFN-γ
treatment. The thioredoxin induction by IFN-γ was insensitive to cycloheximide treatment,
suggesting that it is a primary response gene induced by IFN-γ. Subsequent analysis of the signaling
pathways indicated that the Jak/Stat, Akt, and Erk pathways play a role in IFN-γ signaling that leads
to thioredoxin gene expression. Thioredoxin was induced by oxidative or radiation stresses, and
it protected the immune cells from apoptosis by reducing the levels of reactive oxygen species.
Furthermore, thioredoxin modulated the oxidant-induced cytokine balance toward Th1 by
counter-regulating the production of IL-4 and IFN-γ in T cells.
Conclusion: These data suggest that thioredoxin is an IFN-γ-induced factor that may play a role
in developing Th1 immunity and in the maintenance of immune homeostasis upon infection,
radiation, and oxidative stress.
Background
IFN-γ is a pleiotropic cytokine with a broad range of anti-
viral and immuno-modulatory actions. It is induced by
various immune triggers and plays a critical role in direct-
ing cellular immune responses and inflammation against
infection caused by intracellular pathogens such as viruses
and certain bacteria to function as a Th1 type cytokine [1-
3]. In addition, IFN-γ also regulates cell growth affecting
differentiation, survival, and apoptosis in a wide range of
cell types [4]. These actions of IFN-γ are shown to be
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gene products which include interferon regulatory factors
[5,6], antiviral factors [7-9], chemokines [10,11], cytokine
receptors [12], signaling molecules [13,14], and apopto-
sis-regulatory factors [15,16]. As a part of our ongoing
investigation of the mechanisms involved in regulation of
the Th1 and Th2 immune response, we screened for novel
target genes whose expressions are differentially regulated
by Th1 and Th2 cytokines by performing differential dis-
play-polymerase chain reaction (DD-PCR) analysis with
human peripheral blood mononuclear cells (PBMCs).
From such analysis human thioredoxin (Trx-1) was iden-
tified as a novel target specifically induced by IFN-γ.
Mammalian thioredoxins are a family of proteins that
contain a conserved -Trp-Cys-Gly-Pro-Cys-Lys- catalytic
site. When combined with glutathione, thioredoxins con-
stitute a major group of redox proteins responsible for the
regulation of intracellular redox status [17,18]. During the
redox regulation, thioredoxin undergoes reversible oxida-
tion/reduction of the two cysteine groups. The dithiol(-
SH) form of thioredoxin reduces oxidized protein sub-
strates that contain a disulfide group, and the oxidized
form then cycles back in an NADPH-dependent process
that is mediated by thioredoxin reductase, another pro-
tein that contains a thiol group [19,20]. Thioredoxin is
released from the cell in a redox-sensitive manner, and the
serum thioredoxin level is considered to be an indicator of
oxidative stress, especially in cases of liver diseases
[21,22].
It was initially reported that human thioredoxin stimu-
lated the growth of transformed T and B cell lines [23,24].
Since then, it has been suggested that thioredoxin has
both apoptotic and survival functions in diverse cell sys-
tems [25]. Recently, studies evaluating the anti-apoptotic
effect of thioredoxin have indicated that thioredoxin,
through its redox-control functions, affects cell growth
and survival by perturbation of specific apoptosis signal-
ing molecules, such as apoptosis-stimulating kinase-1
[26,27]. In addition, it has been reported that truncated
thioredoxin (Trx80) stimulates monocytes/macrophages
to induce IL-12, implying that it is involved in immune-
inflammatory reactions that direct Th1 immunity and
IFN-γ production [28].
In light of these findings which suggest that thioredoxin
functions in the regulation of immune cell growth and
possibly in Th1 immune response, it was interesting for us
to identify thioredoxin as a novel target induced by IFN-γ
in cells of immunological origin. Therefore, we examined
the mechanism by which IFN-γ induces and regulates
thioredoxin gene expression. In addition, we evaluated
the role that thioredoxin plays in immune cell survival
and cytokine production upon oxidative stress. The results
of this study shed light on the coordinated immune
defense function of IFN-γ and thioredoxin during diverse
stress responses to infection and apoptotic stimuli.
Results
1. Identification of thioredoxin as a novel target induced 
by IFN-γ
During DD-PCR screening for novel factors involved in
the modulation of Th1 and Th2 immune response, we
identified a number of target genes that were differentially
regulated by Th1 and Th2 cytokines [29,30]. In particular,
by screening mRNAs isolated from human PBMCs stimu-
lated with IL-4 and/or IFN-γ by DD-PCR, Clone A1 was
first noted as a product selectively induced upon stimula-
tion by IL-4 and IFN-γ, but not by IL-4 alone, indicating
that it is an IFN-γ-induced factor. By using Clone A1 as a
probe on a Northern blot analysis of human PBMCs, a
specific induction by IFN-γ of a single mRNA species with
550 bases was detected (see Additional file 1). Subsequent
cloning and sequence analysis revealed that Clone A1
contained part of the 3' coding and the 3'UTR sequence of
human thioredoxin as in MGC:5174 (Genebank acces-
sion # BC003377). Subsequently, screening of Jurkat T
cell cDNA expression libraries using the Clone A1 probe
and the RT-PCR cloning produced a clone of full-length
thioredoxin cDNA that was comprised of 530 bases cod-
ing 105 amino acids, including the conserved 31Trp-Cys-
Gly-Pro-Cys35 motif (see Additional file 1) which was
identical to the previously reported sequence of human
thioredoxin [31].
2. Regulation of thioredoxin gene expression by IFN-γ in 
immune cells
Using a full-length cDNA probe for thioredoxin, the
induction and regulation of human thioredoxin gene
expression by IFN-γ was examined in various immune
cells. Northern blot analysis revealed that IFN-γ signifi-
cantly up-regulated the thioredoxin mRNA levels in THP1
monocytic cell line and Jurkat T cell line, although the up-
regulation was less significant in Jurkat cells. Conversely,
IL-4, a prototypic Th2 cytokine, did not have an inducing
effect on the thioredoxin mRNA levels in these cells (Fig
1A-a, b). RT-PCR analysis also revealed a similar regula-
tion pattern of thioredoxin gene expression in IFN-γ- or
IL-4-treated THP1 and Jurkat cells. (see Additional file 2).
The thioredoxin-inducing effect of IFN-γ was also seen in
Ramos B cells and human PBMCs [32]. Taken together,
these data indicate that the induction of thioredoxin gene
expression by IFN-γ is common to various types of
immune cells.
Prior studies evaluating human thioredoxin mRNA
expression and regulation in immuno-competent cells
have shown that, although the constitutive level of thiore-
doxin expression is relatively low in primary lymphocytesPage 2 of 15
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these cells upon activation by mitogens such as PMA,
PHA, and LPS [31,33]. In fact, we observed the induction
of thioredoxin by PMA, PHA, and LPS in Jurkat T cells and
THP1 cells in this study (Fig 1B-a, b). However, the mech-
anisms by which thioredoxin induction occurs in
response to these mitogens appear to differ, as indicated
by the differential effects of anti-IFN-γ antibodies on
thioredoxin gene expression induced by LPS and PHA.
Specifically, treatment of cells with anti-IFN-γ suppressed
the thioredoxin-inducing effect of PHA, suggesting that
PHA-induced thioredoxin expression is mediated by the
action of IFN-γ (Fig 1B-b).
While IFN-γ induced prominent up-regulation of thiore-
doxin in monocytic cells, neither IL-2 nor IFN-α had a sig-
nificant enhancing effect on thioredoxin expression in
these cells (Fig 1A-c). The up-regulation of thioredoxin by
Regulation of thioredoxin gene expression in immune cell linesFig re 1
Regulation of thioredoxin gene expression in immune cell lines. A. Regulation of thioredoxin gene expression 
by cytokines in immune cell lines. Human lymphocytic T cell line, Jurkat (Panel a) and the promonocytic cell line, THP1 
(Panels b and c), were maintained in complete RPMI media. Cells (5 × 106) were then treated with various cytokines (10 ng/
ml IFN-γ, 10 ng/ml IL-4, 10000 u/ml IFN-α, and 10 ng/ml IL-2) as indicated for 24 h. The total RNA was then isolated and ana-
lyzed by Northern blot using a full-length cDNA probe of human thioredoxin. The membranes were stripped and reprobed for 
β-actin as an internal control. B. Effect of IFN-γ and mitogens on thioredoxin gene expression. Panel a: Jurkat T cells 
(2 × 106) were treated with IFN-γ (10 ng/ml), LPS (1 μg/ml), PMA (10 ng/ml) or PHA (2.5 μg/ml) in serum-free media for the 
indicated durations, after which RNAs were isolated and analyzed by RT-PCR using primers specific for thioredoxin. Panel b: 
THP1 monocytic cells (2 × 106) were treated with IFN-γ (10 ng/ml), LPS (1 μg/ml), or PHA (2.5 μg/ml) in the presence or 
absence of anti-IFN-γ Ab (10 μg/ml). The cells were then cultured for 24 h, after which the total RNA was isolated and ana-
lyzed by RT-PCR using primers specific for thioredoxin and IFN-γ.
A                           B 
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functional implication, since mononuclear phagocytes
are the primary target of IFN-γ during the immune and
inflammatory responses that involve redox-regulatory
mechanisms during the respiratory burst [34]. Therefore,
we evaluated the mechanism by which thioredoxin induc-
tion by IFN-γ occurred in monocytic cells using the THP1
cell line.
3. Induction and regulation mechanism of thioredoxin 
expression by IFN-γ
To confirm the specificity of thioredoxin gene regulation
by IFN-γ, we examined the dose-dependency and kinetics
of thioredoxin mRNA induction by IFN-γ. Treatment of
THP1 cells with increasing doses of IFN-γ from 1 to 20 ng/
ml resulted in up to a 2.7 fold increase in thioredoxin
mRNA levels in a dose-dependent manner (Fig 2A). Fur-
thermore, kinetic analysis of the thioredoxin mRNA
induction revealed that, although the mRNA level gradu-
ally increases with time in response to IFN-γ treatment
both in the presence and absence of serum, a more prom-
inent induction was noted under serum-starved condi-
tions. The thioredoxin induction occurred within 4 h and
significantly increased by 16 h post IFN-γ treatment under
serum-free conditions (Fig 2B, panels a and b). Moreover,
this up-regulation of thioredoxin mRNA levels by IFN-γ
was not inhibited by the translational inhibitor, cyclohex-
imide, which suggests that the IFN-γ-mediated induction
of thioredoxin is a primary response which does not
require on-going protein synthesis (Fig 2B, panel c). The
induction of thioredoxin by IFN-γ was also observed at
the protein level which kinetically followed the induction
of thioredoxin mRNA production. This increase in protein
level began within 6 h, and then gradually accumulated
for 24 h, ultimately increasing by the same magnitude
(2.7 fold) as the mRNA (Fig 3). Taken together, these data
indicate that IFN-γ up-regulates the thioredoxin protein
levels in monocytic cells through the induction of gene
expression.
Because the up-regulation of thioredoxin gene expression
appeared to occur as a direct response to IFN-γ without
involving on-going protein synthesis in IFN-γ-treated
cells, we evaluated the initial signaling pathways involved
in the IFN-γ-mediated induction of thioredoxin gene
expression. The analysis of the signal pathways induced
by IFN-γ in monocytic cells revealed that, in addition to
the well-known Jak1/Stat1 pathways [35], IFN-γ generates
strong activating signals for Akt, Erk and p38 MAPK
within 15 to 60 min (Fig 4A). Treatment with inhibitors
of Jak tyrosine kinases (AG490), PI3K/Akt (LY294002)
and Erk (PD98059) suppressed the IFN-γ-induced effect
on thioredoxin mRNA levels, but treatment with inhibi-
tors of p38 MAPK (SB203580) and Jnk (SP600125) did
not (Fig 4B). Additionally, use of a broad-spectrum tyro-
sine kinase inhibitor, tyrophostin, produced a similar
inhibitory effect (data not shown). These results suggest
that the early activation of Jak/Stat1, PI3K/Akt and Erk,
but not p38 or Jnk, is involved in the IFN-γ-mediated
induction of thioredoxin gene expression. Next, we exam-
ined the downstream effectors of these kinases which
might act as transcriptional activators for thioredoxin
gene expression. In addition to Stat1 which acts as a key
transcription factor during IFN-γ signaling, AP-1(c-fos/c-
jun) and NF-κB were chosen for analysis because these
factors were implicated in the regulation of gene expres-
sion involved in redox response. The nuclear transloca-
tion profile indicated that there was a strong activation of
Stat1 and c-jun/c-fos within 15 min and a weak activation
of p65/NF-κB within 30 to 60 min upon IFN-γ treatment
(Fig. 4C). The activation of Stat1 and AP-1 may occur
through Jak1- and Erk/Akt-dependent phosphorylation,
respectively. Despite a weak activation of p65/NF-κB by
IFN-γ in these cells, its involvement in thioredoxin gene
expression is unlikely, since PDTC (an NF-κB inhibitor)
had no effects on the IFN-γ-induced thioredoxin mRNA
levels. Hence, the data suggest that Stat1 and AP-1, but not
NF-κB may play a role in IFN-γ signaling pathways which
lead to thioredoxin gene expression.
4. Role of thioredoxin in the oxidant- or irradiation-
induced stress response to regulate immune cell survival 
from apoptosis mediated byROS
One of the most recognized functions of thioredoxin is its
ability to increase cellular reductive power and reduce
proteins that have been damaged by oxidative stress or
various ROS-inducing stimuli [36]. Therefore, we first
evaluated the effect of ROS-inducing stimuli on thiore-
doxin gene expression and compared these effects with
those of IFN-γ. As indicated in previous studies [36],
hydrogen peroxide or gamma irradiation at sub-lethal
doses induced a noticeable up-regulation of thioredoxin
gene expression within 24 h (Fig 5A-a, b). In addition, the
magnitude of thioredoxin induction that occurred in
response to both IFN-γ and irradiation treatment was
comparable (2.0~2.5 fold); however, no additive or syner-
gistic effects were observed upon combined treatment.
These findings suggest that IFN-γ and gamma irradiation
induce thioredoxin through a common or converging
pathway (Fig 5A-c).
To examine the role that thioredoxin plays in immune cell
survival during apoptotic stress, we analyzed the effect of
thioredoxin expression on the apoptosis induced by oxi-
dative or radiation stress. We found that monocytic cells
generated ROS and showed an apoptotic response upon
exposure to 50 Gy of γ-irradiation, and that transfection of
thioredoxin substantially suppressed the ROS levels and
partially protected the cells from the irradiation-induced
apoptosis (Fig 5B). Similarly, apoptosis induced byPage 4 of 15
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forced expression of thioredoxin in target cells (data not
shown). The results are in agreement with the study con-
ducted by Ferret et al. [37], which demonstrated that
transfected thioredoxin protected THP1 monocytic cells
from NO-mediated cellular injury. Together these data
indicate that human thioredoxin plays a role in immune
cell survival upon exposure of cells to ROS-inducing stim-
uli, such as hydrogen peroxide or gamma irradiation.
Up-regulation of thioredoxin gene expression by IFN-γ in monocytic cellsFigure 2
Up-regulation of thioredoxin gene expression by IFN-γ in monocytic cells. A. Dose-dependent induction of 
thioredoxin mRNA by IFN-γ. THP1 monocytic cells (5 × 106) were treated with varying doses of IFN-γ in complete media 
for 24 h, after which the RNA was isolated and the thioredoxin gene expression was analyzed by Northern blot analysis as 
described in Fig 1. Panel a: Northern blot autoradiogram. Panel b: Densitometric analysis of the data in panel a. The values 
represent the fold induction of thioredoxin mRNA levels, which were calculated after normalization against β-actin by taking 
the untreated control value as 1. B. Kinetics of thioredoxin gene induction by IFN-γ and the effect of cyclohex-
imide. Panel a: THP1 cells were treated with IFN-γ (10 ng/ml) in complete media for the indicated time periods, after which 
the RNA was isolated and analyzed for thioredoxin gene expression by Northern blot analysis as described in Fig 1. Panel b: 
THP1 cells that had been maintained in complete media were washed thoroughly and then treated with IFN-γ (10 ng/ml) under 
serum-free conditions ("serum-free") or serum starved conditions for 48 h prior to IFN-γ treatment ("serum-starved"). The 
cells were then harvested after the indicated time periods, after which their thioredoxin mRNA levels were determined by 
Northern blot analysis. Panel c: THP1 cells were treated with IFN-γ under serum-free conditions as described for panel b, 
with or without pretreatment with cycloheximide (30 μg/ml) for 3 h. The cells were then cultured for an additional 4 h follow-
ing IFN-γ treatment, after which the thioredoxin mRNA levels were determined by Northern blot.
A                                  B 
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the induction of IFN-γ during oxidative stress
To assess the immunological functions of IFN-γ-induced
thioredoxin during oxidative stress, we examined the
effect of thioredoxin on T cell cytokine balance. It has
been reported that exogenously added Trx80 stimulates
IL-12 production and enhances CD14 expression on
monocytes in PBMC cultures [28]. In addition, it has been
suggested that the intracellular thiol redox status of mac-
rophages plays a role in the regulation of cytokine balance
towards Th1 in thioredoxin-transgenic mice during aging
[38]. Conversely, several studies have shown that oxida-
tive stress and ROS signaling tend to increase Th2 cytokine
production and induce a Th2-biased cytokine profile
[39,40]. Therefore, we evaluated the effect of thioredoxin
to determine if it regulates the Th1/Th2 cytokine balance
during oxidative stress. It was observed that stimulation
with anti-CD3 plus anti-CD28 effectively induced both
IL-4 and IFN-γ expression in cytokine-producing Jurkat T
cells and that hydrogen peroxide treatment selectively
suppressed the IFN-γ gene expression induced by anti-
CD3 plus anti-CD28, resulting in the cytokine balance
leaning towards Th2 (Fig 6, lane 2 vs. lane 3). Noticeably,
in Jurkat T cells that were transfected with thioredoxin, the
IFN-γ mRNA levels were upregulated, whereas the IL-4
mRNA levels were down-regulated (Fig 6, lane 3 vs. lane
6). These results demonstrate that the oxidant-induced
Th2-biased cytokine response is counteracted by thiore-
doxin, which suggests that thioredoxin plays a role in Th1
immunity through the induction of IFN-γ.
Next, in order to investigate the role of thioredoxin on
cytokine production in primary immune cells, we treated
human PBMCs with recombinant human thioredoxin
(hrTrx) and then analyzed the cytokine-producing cell
populations for IFN-γ and IL-4 using intracellular
cytokine staining (Fig 7A). Upon hrTrx treatment,
mitogen-induced IFN-γ-producing cells were increased
(30.8 vs. 38.2%), while IL-4-producing cells were
decreased (16.0 vs. 8.8%), which resulted in a clear shift
towards Thl. Furthermore, analysis by quantitative RT-
PCR revealed that, in accordance with the increase in IFN-
γ-producing cells, hrTrx treatment significantly up-regu-
lated the mitogen-induced IFN-γ mRNA levels by 2-fold
(Fig 7B).
Discussion
As a part of our on-going investigation on the regulation
mechanism involved in Th1 and Th2 immune response,
we conducted DD-PCR analysis of human PBMCs to
screen for novel target genes differentially regulated by
Th1 and Th2 cytokines. The results of our screening
revealed that human thioredoxin was selectively induced
by IFN-γ, but not by IL-4, in various immune cells.
Human thioredoxin was originally identified as a soluble
factor produced by HTLV- or EBV-transformed lymphob-
lastoid cell lines which stimulated the growth of these cell
lines [24]. While the constitutive levels of thioredoxin
were diverse depending on the cell types [31,33], rela-
tively low thioredoxin mRNA expression levels in
immune cells were generally enhanced upon mitogen or
oxidant treatment. We have also noted that various
mitogens were capable of thioredoxin induction in T and
monocytic cells within 24 h. More importantly, we have
demonstrated that thioredoxin is up-regulated up to 3
fold by a prototypic Th1 cytokine IFN-γ in various
immune cell types including PBMCs and B cells [32] as
well as T and monocytic cells (Fig 1). In monocytic cells,
the thioredoxin-inducing effect is specific to IFN-γ, while
other cytokines such as IL-2 and IFN-α, had no effect on
thioredoxin expression (Fig 1A and 1B). The prior incuba-
tion of cells with neutralizing antibodies to human IFN-γ
suppressed the increase in thioredoxin mRNA levels that
was induced by IFN-γ and PHA, but not the increase
caused by LPS, suggesting that PHA-induced thioredoxin
expression is mediated by IFN-γ (Fig 1B). The up-regula-
tion of thioredoxin gene expression in monocytic cells
was more prominent under serum-free conditions than
serum-rich conditions (Fig 2B), which suggests that
growth factors contained in the serum may affect the reg-
ulation of thioredoxin levels.
To elucidate the regulation mechanism by which the
thioredoxin gene is induced by IFN-γ, we conducted a
kinetic analysis and examined the signaling pathways
involved in regulation of gene using a monocytic cell line.
The increase in mRNA levels induced by IFN-γ was kineti-
cally followed by increased production of thioredoxin
protein, and the same magnitude of induction was
obtained at the mRNA and protein levels. These findings
indicate that IFN-γ-induced thioredoxin gene expression
leads to increased protein production. The up-regulation
of thioredoxin mRNA by IFN-γ was not affected by
cycloheximide, a translational inhibitor. This observation
suggests that the induction of thioredoxin is a primary
response to IFN-γ, which does not require on-going pro-
tein synthesis or other IFN-γ-induced protein products.
Therefore, the early IFN-γ signaling pathways would
directly influence the activation of transcription factors
responsible for the thioredoxin gene expression. The sub-
sequent analysis of the IFN-γ-activated signaling transduc-
tion pathways and the subsequent experiments evaluating
the effects of specific signaling inhibitors showed that the
IFN-γ-induced up-regulation of the thioredoxin gene
expression involves Jak, PI3k/Akt and Erk-dependent
pathways, which lead to the activation of specific tran-
scription factors.
Although several transcription factors have been impli-
cated in the regulation of thioredoxin gene expression inPage 6 of 15
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and ATFII, relatively little is known about the mechanism
by which these transcription factors are activated, their
binding to responsive elements, or the eventual transcrip-
tional activation of the thioredoxin gene [41,42]. How-
ever, a close examination of the human thioredoxin gene
promoter sequence revealed the presence of putative
binding sites for the Stat proteins (GAS). This observation
together with the data that early activation of Jak1/Stat1
during IFN-γ signaling and the effect of Jak inhibitors on
thioredoxin gene expression, strongly suggest that tyro-
sine-phophosphorylated Stat1 plays a direct role in the
stimulation of IFN-γ-induced thioredoxin gene expression
(Fig 4-A, B, and 4C). In addition, IFN-γ induced early
nuclear translocation of c-jun and c-fos, and a weak
delayed activation of NF-κB (Fig 4C). The activation of
AP-1 and NF-κB by Erk and PI3K/Akt-dependent phos-
phorylation have been suggested [43,44], which correlates
with the result in Fig 4-B. However, the role of these tran-
scription factors in IFN-γ-activated thioredoxin gene
expression needs to be investigated in more detail in
future studies.
One of the factors recently found to play a key role in anti-
oxidant response is nuclear factor-erythroid 2-related fac-
tor (Nrf). Nrf binds to the antioxidant response element
(ARE) present in the promoter of detoxifying or anti-oxi-
dant enzymes such as heme oxygenase-1, glutathione-S-
transferase, thioredoxin reductase, and thioredoxin [45].
Because the Nrf binding site located on the thioredoxin
promoter overlaps the AP-1 site [46], it is possible that the
AP-1 activating signal of IFN-γ replaces the transcriptional
activation of the thioredoxin gene via the Nrf/ARE ele-
ment. However, few studies evaluating the regulation
mechanism of thioredoxin gene expression by cytokines
or growth factors have been conducted to date. Therefore,
detailed studies evaluating the IFN-γ signaling pathways
that lead to transcriptional activation of the thioredoxin
gene should be performed to provide information regard-
ing the mechanism by which transcriptional regulation of
thioredoxin expression occurs.
The induction of thioredoxin expression by IFN-γ noted in
various immune cells in our study may have an important
functional implication. We found that sub-lethal doses of
hydrogen peroxide or gamma irradiation induced thiore-
doxin, but that this induction was delayed (Fig 5). This
finding is in agreement with the well-recognized roles that
thioredoxin plays in defense against oxidants and radia-
tion stress generating ROS. However, the administration
of lethally high doses of these agents often leads to the
early suppression of thioredoxin levels and subsequent
cell death (data not shown). In our study, IFN-γ-induced
thioredoxin gene expression occurred earlier (4 h; Fig 2)
than oxidative- or radiation stress-mediated induction of
thioredoxin (16–24 h), and co-treatment with IFN-γ and
irradiation stress did not exert a synergistic effect on the
induction of thioredoxin (Fig 5A). Taken together, these
observations suggest that gamma irradiation and IFN-γ
induce thioredoxin expression through a common path-
way, and that IFN-γ acts as a mediator of irradiation-
induced thioredoxin up-regulation.
Thioredoxin has long been recognized for its ability to
protect cells from apoptotic stress. For example, in a
murine lymphoid cell line WEHI7.2, the transfection and
over-expression of human thioredoxin was found to sup-
Up-regulation of the thioredoxin protein levels by IFN-γFigure 3
Up-regulation of the thioredoxin protein levels by 
IFN-γ. THP1 cells (5 × 105) were treated with media alone 
or with IFN-γ under serum-free conditions for the indicated 
time periods. The cells were then treated with brefeldin A 
(10 μg/ml) for 4 h prior to being harvested, after which they 
were permeabilized and stained with mouse monoclonal anti-
thioredoxin antibodies and mouse IgG-FITC as described in 
the text. FACS analysis was performed to determine the 
intracellular protein levels based on their MFI values. Panel 
A: A representative FACS histogram. Panel B: ΔMFI values 
for thioredoxin levels. Each value shown represents the 
mean of three independent determinations.
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and peroxide, in a manner similar to Bcl2 over-expression
[47]. However, the mechanism by which thioredoxin
exerts its anti-apoptotic effect against different stress
responses is not clearly known, while it appears to vary
depending on the nature of the stimuli and the types of
Analysis of signaling pathways activated by IFN-γ and the effects of signaling inhibitors on thioredoxin gene expressionFigure 4
Analysis of signaling pathways activated by IFN-γ and the effects of signaling inhibitors on thioredoxin gene 
expression. A. Analysis of Jak, Akt, and MAPK pathways during IFN-γ signal transduction in THP1 cells. THP1 
cells (1 × 106) were treated with media alone or IFN-γ under serum-free conditions for the indicated times. The total cell 
lysates were then prepared and analyzed by Western blot to determine the activation status of Jak1/Stat1, Akt, and MAPKs as 
described in the text. B. Effects of signaling inhibitors on IFN-γ-induced thioredoxin gene expression. THP1 cells (1 
× 106) were pretreated with LY294002 (20 μM), PD98059 (50 μM), SP600125 (10 μM), AG490 (10 μM), PDTC (100 μM) or 
SB203580 (20 μM) for 1 h and then cultured for an additional 24 h in the presence or absence of IFN-γ under serum-free con-
ditions. The total RNA was isolated and the thioredoxin mRNA levels were then analyzed by RT-PCR. C. Analysis of activa-
tion and nuclear translocation of Stat1, NF-κB, and AP-1 induced by IFN-γ in THP1 cells. Cells (5 × 106) were 
treated with media alone or IFN-γ (10 ng/ml) under serum-free conditions for the indicated times. The cells were then har-
vested and used to prepare cytoplasmic or nuclear extracts. The extracts were then subjected to Western blot to determine 
the activation status of Stat1, c-Jun, c-fos or NF-κB, using antibodies to anti-phosphotyrosine Stat1, anti-Stat1, c-Jun, c-fos and 
NF-κB (p65). As internal controls, Cox-4 and H2A were used for cytosolic and nuclear marker proteins, respectively.
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cates that thioredoxin over-expression suppresses the irra-
diation- or oxidant-induced apoptosis in immune cell
lines, and that such anti-apoptotic function of thiore-
doxin is associated with the ROS-scavenging effect
observed in thioredoxin-transfected cells.
The redox-regulation of mononuclear phagocytes plays an
important physiological role in the defense against micro-
bial infection and inflammation, as well as in the proper
cellular response to a wide variety of stress conditions
evoked by hypoxia/oxidants, nutrient starvation, DNA
damaging agents, and ionizing radiation [50]. It is now
apparent that thioredoxin is a key defense molecule
involved in the regulation of homeostasis in cells sub-
jected to diverse stresses [19,50]. On the other hand, the
functions of IFN-γ as an immuno-regulatory cytokine
include macrophage activation for effective antigen
processing and presentation upon pathogen uptake via
up-regulation of MHC molecules [51], activation of lyso-
somal enzymes [52], and regulation of ROS-generating
enzymes such as NADPH oxidases [53,54], myeloperoxi-
dases [55] and superoxide dismutases [56]. Recently, an
IFN-γ-inducible thiol-containing lysosomal enzyme,
GILT, which plays a role in the control of oxido-reduction
reactions in the lysosome during antigen processing, was
identified [57,58]. These findings indicate that there is a
casual mechanistic link between redox regulation of the
thioredoxin system and IFN-γ-mediated macrophage acti-
vation, which functions as an important defense mecha-
nism that maintains immune homeostasis upon infection
and inflammation.
It has been reported that mammalian thioredoxins are
produced in several forms different in size and structure.
In addition to the classical cytosolic Trx-1 [31] and mito-
chondrial Trx-2 [59], a minor cytosolic TRP14 [60] and
Trx80 [61] have been identified. The 12 kD Trx-1 and C-
terminal truncated 10 kD Trx80 are known to be secreted
from the cell and believed to act as a co-cytokine to regu-
late immune cell functions [61,62]. Denaturing SDS-
PAGE analysis of IFN-γ-treated THP-1 cells revealed that
the IFN-γ-induced thioredoxin identified in the present
study has a deduced molecular weight of 12 kD (Fig S1)
and an apparent molecular weight of 14 kD (data not
shown), which indicate that it is the cytosolic full-length
Trx-1 [31]. The reported cytokine-like activities of both
full-length and truncated thioredoxin include stimulation
of immune cell proliferation, macrophage differentiation
and chemotaxis, and production of inflammatory
cytokines such as IL-I, IL-6, IL-8, and TNF [63-65].
Of particular interest is the finding that Trx80, when co-
treated with IL-2, promoted the production of IL-12 and
IFN-γ by human PBMCs [28], which suggests that thiore-
doxin can act as a potential inducer of Th1 immunity and
that there is a functional link between thioredoxin and
IFN-γ. In line with this, our data demonstrate that thiore-
doxin over-expression induces T cells to counteract the
oxidant-induced Th2 bias and reverse cytokine balance by
up-regulating IFN-γ gene expression (Fig 6). Furthermore,
a Th1-inducing effect of thioredoxin was observed in
human primary CD4+ T cells, as shown by changes
between the IL-4 and IFN-γ-producing populations in
response to treatment with hrTrx (Fig 7A). Specific induc-
tion of IFN-γ mRNA in PBMCs treated with hrTrx further
supported the up-regulation of Th1 response by thiore-
doxin (Fig 7B). The induction of thioredoxin by IFN-γ and
the restoration of IFN-γ levels by thioredoxin during oxi-
dative stress in immune cells found in this study, suggest
that thioredoxin and IFN-γ may have evolved to serve
complementary functions through positive feedback
mechanisms during immune inflammatory conditions.
Conclusion
We have demonstrated that human thioredoxin is a novel
target gene induced by IFN-γ. In addition, we showed that
thioredoxin may play a role in the protection of immune
cells from apoptosis and in the counter-regulation of
cytokine production evoked by ROS-generating stimuli.
Therefore, thioredoxin induced by IFN-γ upon infection,
stress, or immune triggers for Th1 immune response
appears to act as a protective factor that maintains
immune cell homeostasis through mechanisms involving
ROS-scavenging, anti-apoptotic and cytokine-regulating
functions.
Methods
Cells and cell culture
PBMCs were isolated from the freshly-drawn blood of
healthy donors using Ficoll-Hypaque density gradient
centrifugation. Flow cytometry revealed that the mononu-
clear cell preparation typically contained approximately
70% T cells, 15~20% B cells, and 10~15% monocytes. The
human monocytic cell lines, THP1 and U937, and the T
lymphocytic leukemic cell line, Jurkat, were obtained
from ATCC and maintained in complete RPMI media
containing 10 mM Hepes (pH 7.5), 50 μM β-mercap-
toethanol, and 10% FBS (Life Technologies Inc., Grand
Island, NY USA). The cells were then treated with recom-
binant human IFN-γ, IL-4, IL-2 (R & D systems, Minneap-
olis, MN, USA) or IFN-α (Roche, Nutley, NJ USA) in the
presence or absence of serum, after which the cells were
cultured for various lengths of time at 37°C under 5%
CO2.
DD-PCR screening and cloning
PBMCs were cultured in the presence of 10 ng/ml of IFN-
γ and/or IL-4, after which the total RNA was isolated using
4 M GITC and 5 M CsCl and ultracentrifugation. DD-PCRPage 9 of 15
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GenHunter, Nashville, USA) according to the manufac-
turer's instructions, and the amplified products were dis-
played on a 6% polyacrylamide gel. Next, PCR product
bands that were selected based on their differential expres-
sion were purified from the gel, reamplified, and ligated
into a pUC18/SmaI vector at 16°C for 48 h. E. Coli was
then transformed with the ligated vectors, after which
Role of thioredoxin in the oxidant- or gamma irradiation-induced stress response and apoptosisFigure 5
Role of thioredoxin in the oxidant- or gamma irradiation-induced stress response and apoptosis. A. Induction 
of thioredoxin gene expression by oxidants and gamma irradiation. THP1 monocytic cells were treated with media 
alone or with varying doses of hydrogen peroxide for 24 h (Panel a). Cells were exposed to varying doses of gamma irradia-
tion (γ-IR) and further cultured for 16 h (Panel b). Cells were treated with media alone, IFN-γ (10 ng/ml), γ-IR (5 Gy), and 
IFN-γ plus γ-IR for 16 h (Panel c). Total RNA was prepared and analyzed by Northern blot to determine the thioredoxin 
mRNA levels. B. Protective function of thioredoxin against gamma irradiation-induced apoptosis. U937 monocytic 
cells were either mock-transfected with empty vector (-) or transfected with thioredoxin expression construct (+) and then 
cultured for 40 h. The cells were then exposed to 50 Gy of γ-IR, after which they were analyzed for ROS generation at 30 min 
(upper box) and apoptosis at 16 h (lower box) as described in the text.
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mids were then purified and sequenced using a previously
described method [29].
Northern blot and RT-PCR analysis of thioredoxin
Cells were treated with various cytokines for the indicated
times, after which the total RNA was isolated. Next, the
RNA was separated on a 1% agarose gel, transferred to
nylon membranes, and then hybridized with a radio-
labeled probe of a full-length human thioredoxin cDNA.
Densitometric analysis of the blots was then performed
using ImageQuant (Molecular Dynamics, Sunnyvale, CA,
USA). RT-PCR analysis of thioredoxin was performed
using standard protocols. Briefly, RNAs (1~2 μg) were
reverse-transcribed and then subjected to 30 cycles of PCR
amplification using a thermal cycler (GeneAmp PCR Sys-
tem 2400, Applied Biosystems, USA) and the following
thioredoxin specific primers: 5' primer, CTTTGGATC-
CATTTCCATC; 3' primer, GCATTAATGTTTTATTGT-
CACG., as described [32].
Intracellular staining of thioredoxin
Cells were cultured in serum-free medium and then
treated with IFN-γ for various time periods. To measure
the intracellular levels of thioredoxin, brefeldin A (Sigma,
St. Louis, MO, USA) was added to the cells 4 to 6 h prior
to harvest. Cells were then permeabilized in PBS buffer
containing 0.5% saponin and 1% BSA, after which they
were stained with mouse monoclonal anti-human thiore-
doxin antibodies (American Diagnostics Inc., Stamford,
Connecticut, USA) and anti mouse IgG-FITC. Flow cyto-
metric analysis using a FACS Calibur (BD Bioscience,
Mountain View, CA, USA) was then conducted to deter-
mine the mean fluorescence intensity (MFI) values. The
ΔMFI for each sample was then calculated by subtracting
the MFI of cells that were stained with anti-thioredoxin
antibodies and anti-mouse IgG-FITC from the MFI of cells
that were stained with anti-mouse IgG-FITC only. All val-
ues represent a mean of three independent determina-
tions.
Thioredoxin transfection
Cells were plated at a density of 5 × 106/well in 6-well
plates. cDNA expression constructs for human thiore-
doxin, hTRX-WT (kindly provided by Dr. J. Yodoi, Kyoto
Univ.) cloned into pcDNA Xpress vector or empty vectors
were then introduced into the cells using Superfect rea-
gent (Qiagen, Valencia, USA) according to the manufac-
turer's instructions. At two days (40 to 48 h) after
transfection, the cells were harvested and the thioredoxin
expression levels were determined by immunoblotting
using monoclonal anti-human thioredoxin antibodies.
Immunoblotting
Cells were harvested and the total, cytosolic, or nuclear
extracts were then prepared. Next, the proteins were frac-
tionated by SDS-PAGE, transferred to PVDF membranes,
and then subjected to immunoblot analysis using anti-
bodies to thioredoxin (American Diagnostica Inc.), p65
NF-κB (Upstate Biotechnology, Lake Placid, NY, USA),
H2A, Akt, p-Akt, Erk, p-Erk, Jnk, p-Jnk, p38 and p-p38
(Cell Signaling Technologies, Beverly, MA, USA), Jak1, p-
Jak1, Stat1, p-Stat1, c-fos and c-jun (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), Cox-4 (Invitrogen,
Carlsbad, USA) or β-actin using an ECL detection kit
(Amersham, Uppsala, Sweden).
Apoptosis assays
Cells were treated with 10 to 500 μM hydrogen peroxide
or irradiated at room temperature with a 137Cs γ-source
irradiator at a dose rate of 5.66 Gy/min using an IBL 437
type H irradiator (CIS Biointernational, Nice, France) at 5
to 50 Gys as described previously [66]. The cells were then
incubated at 37°C, after which apoptosis was determined
by cytochrome C release analysis and Annexin V staining
as described [32,67].
ROS measurement
After exposure of the cells to hydrogen peroxide or gamma
irradiation for the indicated time periods, cells were col-
lected and stained with 5 μM each of DHE (Calbiochem,
The effects of oxidants and thioredoxin on cytokine produc-tion in Jurkat T cells: Thioredoxin up-regulates IFN-γ produc-and counteracts 2 cyt k e bias caus d by oxidantsFigure 6
The effects of oxidants and thioredoxin on cytokine 
production in Jurkat T cells: Thioredoxin up-regu-
lates IFN-γ production and counteracts Th2 cytokine 
bias caused by oxidants. Jurkat T cells were either mock-
transfected with empty vector (Mock) or transfected with 
thioredoxin expression construct (Trx) and then incubated 
for 24 h. The cells were then pretreated with hydrogen per-
oxide (400 μM) for 1 h, after which they were incubated with 
media alone or with human anti-CD3 (1 μg/ml) plus anti-
CD28 (1 μg/ml) to stimulate cytokine production for 4 h. 
RT-PCR was then performed to determine the mRNA levels 
of IL-4, IFN-γ, and thioredoxin.Page 11 of 15
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the detection of superoxide anion and hydrogen peroxide,
respectively. The fluorescence was then measured by FAC-
SCalibur analysis. The ROS levels are shown as fluores-
cence intensity, and all values shown represent the mean
of three independent determinations.
Cytokine gene expression analysis
Jurkat T cells were stimulated with anti-CD3 plus anti-
CD28 with or without pretreatment with hydrogen perox-
ide. Following incubation for 4 h, the total RNA was iso-
lated and used for RT-PCR analysis of the cytokine
transcripts using primers specific for human IL-4, IFN-γ,
and β-actin as described previously [68].
Intracellular cytokine staining
Human PBMCs were treated with human recombinant
thioredoxin (hr-Trx, BD Biosciences) for 2 or 16 h. For
intracellular cytokine staining, the cells were stimulated
with 30 ng/ml PMA and 1 μg/ml ionomycin for 5 h in the
presence of brefeldin A at 37°C. Next, the cells were fixed
and permeabilized in Cytofix/Cytoperm buffer, after
which they were stained with FITC-conjugated anti-IFN-γ
and PE-conjugated anti-IL-4 (BD Biosciences). To separate
the CD4+ T cells, these cells were stained with PerCP-con-
jugated anti-CD4 (BD Biosciences). Flow cytometric anal-
ysis was then performed using FACSCalibur to determine
the ratio (%) of cytokine-producing cells.
Real-time RT-PCR
Human PBMCs were treated with hr-Trx for 16 h and then
further cultured with 20 ng/ml PMA and 0.5 μg/ml iono-
mycin for 5 h. Total RNA (1 μg) was then reverse-tran-
scribed, after which real-time PCR amplification with iQ
SYBR Green (Bio-Rad) was performed using a Mastercy-
cler realplex thermalcylcer (Eppendorf AG, Hamburg,
Germany). The results were normalized against GAPDH
by comparing the fold change in the expression of IFN-γ
mRNA to the expression of GAPDH using the 2ΔΔct com-
parative expression method. The following primers were
used: for IFN-γ (198 bases), 5'primer, TCCCATGGGTTGT-
GTGTTTA; 3' primer, AAGCACCAGGCATGAAATCT; for
GAPDH (178 bases): 5' primer, GACATCAAGAAGGTG
GTGAA; 3' primer, TGTCATACCAGGAAATGAGC.
Abbreviations
DD-PCR: differential display-polymerase chain reaction;
γ-IR: gamma irradiation; Jak: Janus tyrosine kinase;
PBMCs: peripheral blood mononuclear cells; ROS: reac-
tive oxygen species; RT-PCR: reverse transcription based
polymerase chain reaction; Stats: signal transducers and
activators of transcription; UTR: untranslated region.
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Effects of recombinant thioredoxin (hr-Trx) on cytokine pro-duction in primary immune cellsFigure 7
Effects of recombinant thioredoxin (hr-Trx) on 
cytokine production in primary immune cells. A. 
Thioredoxin modulates IFN-γ- vs. IL-4-producing 
CD4+ T cell populations. Human peripheral lymphocytes 
(1 × 106) were treated with media alone or with human 
recombinant thioredoxin (hr-Trx) for 2 or 16 h. The cells 
were then stimulated with PMA (30 ng/ml) + ionomycin (1 
μg/ml) in the presence of brefeldin A (10 μg/ml) for 5 h, after 
which they were permeabilized and stained with FITC-conju-
gated anti-human IFN-γ antibodies and PE-conjugated anti-
human IL-4 antibodies. These cells were then restained with 
PerCP-conjugated anti-human CD4 antibodies to enable sep-
aration of the Th cells. FACS analysis was performed to 
determine the intracellular cytokine levels. B. Thioredoxin 
increases the IFN-γ mRNA levels in human PBMCs. 
Human PBMCs (1 × 106) were treated with media alone or 
with hr-Trx for 16 h. The cells were then stimulated with 
PMA (20 ng/ml) + ionomycin (0.5 μg/ml) for 5 h. The total 
RNA was then isolated and analyzed by real time RT-PCR 
using primers specific for IFN-γ. IFN-γ mRNA expression lev-
els were normalized with the internal control, GAPDH.
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performed using primers specific for the full-length thioredoxin cDNA. β-
actin was used as an internal control.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2172-9-64-S2.doc]Page 13 of 15
(page number not for citation purposes)
BMC Immunology 2008, 9:64 http://www.biomedcentral.com/1471-2172/9/6425. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J: Redox
control of cell death.  Antioxid Redox Signal 2002, 4:405-414.
26. Yoshioka J, Schreiter ER, Lee RT: Role of thioredoxin through
interaction with signaling molecules.  Antioxid Redox Signal 2006,
8:2143-2151.
27. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawa-
bata M, Miyazono K, Ichijo H: Mammalian thioredoxin is a direct
inhibitor of apoptosis signal-regulating kinase (ASK) 1.  EMBO
J 1998, 17:2596-2606.
28. Pekkari K, Avila-Cariño J, Bengtsson A, Gurunath R, Scheynius A, Hol-
mgren A: Truncated thioredoxin(Trx80) induces production
of interleukin-12 and enhances CD14 expression in human
monocytes.  Blood 2001, 97:3184-3190.
29. Kong KA, Jang JY, Lee CE: Identification of DC21 as a novel tar-
get gene counter-regulated by IL-4 and IL-12.  J Biochem Mol
Biol 2002, 35:623-628.
30. Jang JY, Lee CE: Mitochondrial adenine nucleotide translocase
3 is regulated by IL-4 and IFN-γ via STAT-dependent path-
ways.  Cell Immunol 2003, 226:11-19.
31. Wollman EE, d'Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P,
Graber P, Dessarps F, Robin P, Galibert F: Cloning and expression
of a cDNA for human thioredoxin.  J Biol Chem 1988,
263:15506-15512.
32. Kang MW, Jang JY, Choi JY, Kim SH, Oh J, Cho BS, Lee CE: Induction
of IFN-gamma gene expression by thioredoxin: positive
feed-back regulation of Th1 response by thioredoxin and
IFN-gamma.  Cell Physiol Biochem 2008, 21:215-224.
33. Sahaf B, Soderberg A, Spyrou G, Barral AM, Pekkari K, Holmgren A,
Rosen A: Thioredoxin expression and localization in human
cell lines: Detection of full-length and truncated species.  Exp
Cell Res 1997, 236:181-192.
34. Gupta JW, Kubin M, Hartman L, Castella M, Trinchieri G: Induction
of expression of genes encoding components of the repira-
tory burst oxidase during differentiation of human myeloid
cell lines induced by tumor necrosis factor and gamma inter-
feron.  Cancer Res 1992, 52:2530-2537.
35. Darnell JE, Kerr IM, Stark GR: Jak-Stat pathways and transcrip-
tional activation in response to IFNs and other extracellular
signaling proteins.  Science 1994, 264:1415-1421.
36. Nakamura H, Nakamura K, Yodoi J: Redox regulation of cellular
activation.  Annu Rev Immunol 1997, 15:351-369.
37. Ferret PJ, Soum E, Negre O, Wollman EE, Fradelizi D: Protective
effect of thioredoxin upon NO-mediated cell injury in THP1
monocytic human cells.  Biochem J 2000, 346:759-765.
38. Murata Y, Amao M, Yoneda J, Hamuro J: Intracellular thiol redox
status of macrophages directs the Th1 skewing in thiore-
doxin transgenic mice during aging.  Mol Immunol 2001,
38:747-757.
39. King MR, Ismail AS, Davis LS, Karp DR: Oxidative stress promotes
polarization of T cell differentiation toward a T helper 2 phe-
notype.  J Immunol 2006, 176:2765-2772.
40. Frossi B, Decardi M, Denaile KC, Rivera J, Puccilo C: Oxidative
stress stimulates IL-4 and IL-6 production in mast cells by an
APE/Ref-1-dependent pathways.  Eur J Immunol 2003,
33:2168-2177.
41. Kaghad M, Dessarps F, Jacquemin-Sablon H, Caput D, Fradelizi D,
Wollman EE: Genomic cloning of human thioredoxin-encod-
ing gene: mapping of the transcription start point and analy-
sis of the promoter.  Gene 1994, 140:273-278.
42. Tonissen KF, Wells JR: Isolation and characterization of human
thioredoxin-containing genes.  Gene 1991, 102:221-228.
43. Blanchette J, Pouliot P, Olivier M: Role of protein tyrosine phos-
phatases in the regulation of interferon-{gamma}-induced
macrophage nitric oxide generation: implication of ERK
pathway and AP-1 activation.  J Leukoc Biol 2007, 81:835-844.
44. Koul D, Shen R, Shishodia S, Takada Y, Bhat KP, Reddy SA, Aggarwal
BB, Yung WK: PTEN down regulates AP-1 and targets c-fos in
human glioma cells via PI3-kinase/Akt pathway.  Mol Cell Bio-
chem 2007, 300:77-87.
45. Tanito M, Agbaga MP, Anserson RE: Upregulation of thioredoxin
system via Nrf2-antioxidant responsive element pathway in
adaptive-retinal neuroprotection in vivo and in vitro.  Free
Radic Biol Med 2007, 42:1838-1850.
46. Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, Yodoi J:
Hemin-induced activation of the thioredoxin gene by Nrf2. A
differential regulation of the antioxidant responsive element
by a switch of its binding factors.  J Biol Chem 2001,
276:18399-18406.
47. Powis G, Kirkpatrick DL, Angulo M, Baker A: Thioredoxin redox
control of cell growth and death and the effects of inhibitors.
Chem Biol Interact 1998, 112:23-34.
48. Powis G, Montfort WR: Properties and biological activities of
thioredoxins.  Annu Rev Pharmacol Toxicol 2001, 41:261-295.
49. Cerutti PA: Prooxidant states and tumor promotion.  Science
1985, 227:375-381.
50. Tanaka T, Nakamura H, Nishiyama A, Hosoi F, Masutani H, Wada H,
Yodoi J: Redox regulation by thioredoxin superfamily; protec-
tion against oxidative stress and aging.  Free Radic Res 2000,
33:851-855.
51. Mach B, Steimle V, Martinez-Soria E, Reith W: Regulation of MHC
class II genes: lessons from a disease.  Annu Rev Immunol 1996,
14:301-331.
52. Lah TT, Hawley M, Rock KL, Goldberg AL: Gamma-interferon
causes a selective induction of the lysosomal proteases,
cathepsins B and L, in macrophages.  FEBS Lett 1995, 363:85-89.
53. Cassatella MA, Bazzoni F, Flynn RM, Dusi S, Trinchieri G, Rossi F:
Molecular basis of interferon-gamma and lipopolysaccharide
enhancement of phagocyte respiratory burst capability.
Studies on the gene expression of several NADPH oxidase
components.  J Biol Chem 1990, 265:20241-20246.
54. Newburger PE, Ezekowitz RA, Whitney C, Wright J, Orkin SH:
Induction of phagocyte cytochrome b heavy chain gene
expression by interferon gamma.  Proc Natl Acad Sci USA 1988,
85:5215-5219.
55. Kawano S, Tatsumi E, Yoneda N, Yamaguchi N: Suppression of
myeloperoxidase gene expression by gamma-interferon.
Hum Cell 1992, 5:282-286.
56. Harris CA, Derbin KS, Hunte-McDonough B, Krauss MR, Chen KT,
Smith DM, Epstein LB: Manganese superoxide dismutase is
induced by IFN-gamma in multiple cell types: Synergistic
induction by IFN-gamma and tumor necrosis factor or IL-1.
J Immunol 1991, 147:149-154.
57. Arunachalam B, Phan UT, Geuze HT, Cresswell P: Enzymatic
reduction of disulfide bonds in lysosomes: Characterization
of a gamma-interferon-inducible lysosomal thiol reductase
(GILT).  Proc Natl Acad Sci USA 2000, 97:745-750.
58. Phan UT, Arunachalam B, Cresswell P: Gamma-interferon-induc-
ible lysosomal thiol reductase (GILT): Maturation, activity,
and mechanism of action.  J Biol Chem 2000, 275:25907-25914.
59. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Musutani H, Ueda
S, Yodoi J: Thioredoxin-2 (TRX-2) is an essential gene regulat-
ing mitochondria-dependent apoptosis.  EMBO J 2002,
21:1695-1703.
60. Jeong W, Yoon HW, Lee SR, Rhee SG: Identification and charac-
terization of TRP14, a thioredoxin-related protein of 14 kDa.
New insights into the specificity of thioredoxin function.  J Biol
Chem 2004, 279:3142-3150.
61. Pekkari K, Gurunath R, Arner ESJ, Holmgren A: Truncated thiore-
doxin is a mitogenic cytokine for resting human peripheral
blood mononuclear cells and is present in human plasma.  J
Biol Chem 2000, 275:37474-37480.
62. Sahaf B, Rosen A: Secretion of 10-kDa and 12-kDa thioredoxin
species from blood monocytes and transformed leukocytes.
Antioxid Redox Signal 2000, 2:717-726.
63. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R,
Caselli G, Pagliei S, Romines B, Wilshire JA, Mengozzi M, Nakamura
H, Yodoi J, Pekkari K, Gurunath R, Holmgren A, Hezenberg LA,
Ghezzi P: Thioredoxin, a redox enzyme released in infection
and inflammation, is a unique chemoattractant for neu-
trophils, monocytes, and T cells.  J Exp Med 1999,
189:1783-1789.
64. Pekkari K, Avila-Cariño J, Grunath R, Bengtsson A, Scheynius A, Hol-
mgren A: Truncated thioredoxin (Trx80) exerts unique
mitogenic cytokine effects via a mechanism independent of
thiol oxido-reductase activity.  FEBS Lett 2003, 539:143-148.
65. Yosida S, Katoh T, Tetsuka T, Uno K, Matsui N, Okamoto T:
Involvement of thioredoxin in rheumatoid arthritis: its cos-
timulatory roles in the TNF-alpha-induced production of IL-
6 and IL-8 from cultured synovial fibroblasts.  J Immunol 1999,
163:351-358.Page 14 of 15
(page number not for citation purposes)
BMC Immunology 2008, 9:64 http://www.biomedcentral.com/1471-2172/9/64Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
66. Rho HS, Park SS, Lee CE: Gamma irradiation up-regulates B cell
differentiation antigen CD23 in human B cells by NF-κB acti-
vation.  J Biochem Mol Biol 2004, 37:507-514.
67. Jang JY, Lee CE: IL-4-induced up-regulation of adenine nucle-
otide translocase 3 and its role in Th cell survival from apop-
tosis.  Cell Immunol 2006, 241:14-25.
68. So EY, Oh J, Jang JY, Kim JH, Lee CE: Ras/Erk pathway positively
regulates Jak1/Stat6 activity and IL-4 gene expression in Jur-
kat T cells.  Mol Immunol 2007, 44:3416-3426.Page 15 of 15
(page number not for citation purposes)
